Cargando…

Lessons from two SARS-CoV-2 waves in South Africa

Detalles Bibliográficos
Autores principales:	Bekker, Linda-Gail, Ntusi, Ntobeko A B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270540/ https://www.ncbi.nlm.nih.gov/pubmed/34252380 http://dx.doi.org/10.1016/S2214-109X(21)00313-2

Ejemplares similares

SARS-CoV-2 reinfection in a closed setting: lessons for the community
por: Velasco, María, et al.
Publicado: (2021)

The challenges of informative wastewater sampling for SARS-CoV-2 must be met: lessons from polio eradication
por: O'Reilly, Kathleen M, et al.
Publicado: (2020)

SARS-CoV-2 and HIV-1 — a tale of two vaccines
por: Haynes, Barton F.
Publicado: (2021)

MERS-CoV in Africa—an enigma with relevance to COVID-19
por: Perlman, Stanley, et al.
Publicado: (2021)

Intense SARS-CoV-2 transmission among affluent Manaus residents preceded the second wave of the epidemic in Brazil
por: Buss, Lewis F, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Neonatal SARS-CoV-2 infection
por: de Carvalho, Werther Brunow, et al.
Publicado: (2020)

Towards SARS-CoV-2 serotypes?
por: Simon-Loriere, Etienne, et al.
Publicado: (2022)

Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection
por: Talarico, Rosaria, et al.
Publicado: (2020)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

Understanding the drivers of transmission of SARS-CoV-2
por: Cornelissen, Laura, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

The SARS-CoV2 pandemic and routine immunisation
por: Kang, Gagandeep
Publicado: (2022)

Sustainability of surveillance systems for SARS-CoV-2
por: Adlhoch, Cornelia, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

Antibodies, epicenter of SARS-CoV-2 immunology
por: Pecetta, Simone, et al.
Publicado: (2021)

Decoding the next SARS-CoV-2 variant
por: Nel, Jeremy, et al.
Publicado: (2022)

Diabetes after SARS-CoV-2 infection
por: Al-Aly, Ziyad
Publicado: (2023)

SARS-CoV-2 infection and cardiac arrhythmias
por: Dewland, Thomas A., et al.
Publicado: (2022)

SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023)

Impact of SARS-CoV-2 exposure history on the T cell and IgG response
por: Keeton, Roanne, et al.
Publicado: (2022)

Outcomes of laboratory‐confirmed SARS‐CoV‐2 infection in the Omicron‐driven fourth wave compared with previous waves in the Western Cape Province, South Africa
por: Davies, Mary‐Ann, et al.
Publicado: (2022)

Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa
por: Davies, Mary-Ann, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
por: Goga, Ameena, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in COVID-19 hotspots
por: Eckerle, Isabella, et al.
Publicado: (2020)

Impact of contact tracing on SARS-CoV-2 transmission
por: Sun, Kaiyuan, et al.
Publicado: (2020)

Who is most likely to be infected with SARS-CoV-2?
por: Jordan, Rachel E, et al.
Publicado: (2020)

SARS-CoV-2: virus dynamics and host response
por: Chen, Yu, et al.
Publicado: (2020)

Persistence of IgG response to SARS-CoV-2
por: Duysburgh, Els, et al.
Publicado: (2021)

Tracking SARS-CoV-2 infection in India with serology
por: John, Jacob, et al.
Publicado: (2021)

Correlates of protection from SARS-CoV-2 infection
por: Krammer, Florian
Publicado: (2021)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

Risks of lung transplantation in the SARS-CoV-2 era
por: Meyer, Keith C
Publicado: (2021)

SARS-CoV-2 evolution and vaccines: cause for concern?
por: Williams, Thomas C, et al.
Publicado: (2021)

Nowcasting towards sustainable SARS-CoV-2 endemicity
por: Leung, Gabriel M
Publicado: (2021)

Addendum: competing interests and the origins of SARS-CoV-2
por: Editors of The Lancet
Publicado: (2021)

Escalating burden of SARS-CoV-2 infection in Ethiopia
por: Adane, Kelemework, et al.
Publicado: (2021)

Spreading of SARS-CoV-2 from hamsters to humans
por: Haagmans, Bart L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_86fin614a0on36gd23b8k8t6fc